Study of Fluid Collection of the Chest in Children With Pneumonia

Overview

The purpose of this study is to determine the best treatment for children with a fluid collection in the chest associated with an underlying pneumonia. Researchers generally agree that a child with a large fluid collection in the chest need to have the fluid drained in addition to anitbiotics. There have been many treatments studied in children that have been shown to be effective and safe, but the treatments have never been compared to each other in a randomized controlled study. The optimal treatment of pediatric parapneumonic effusions remains controversial. The objective of this study is to compare the use of conventional management (antibiotics with thoracostomy tube placement) with primary thorascopic drainage (see protocol). Our hypothesis is that pediatric patients with parapneumonic effusion, regardless of pleural fluid composition and loculations, have decreased morbidity when treated with early thoroscopic adhesiolysis (VATS) compared with conservative treatment.

Full Title of Study: “Parapneumonic Effusion in Children Study”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Treatment
    • Masking: None (Open Label)
  • Study Primary Completion Date: March 2004

Detailed Description

The ultimate objective of this study is to rationalize treatment decisions. It is our hope that this pilot study will provide the basis for further randomized prospective studies. The expected benefit is that the current treatment and outcome of pediatric parapneumonic effusions will be determined. Insights into the therapy that results in the least morbidity, hospital days, (and therefore cost) will be elucidated. If our hypothesis is valid, then a more aggressive surgical approach to the treatment of a parapneumonic effusion may be warranted. If the hypothesis is not valid, then the appropriate treatment for a parapneumonic effusion, irrespective of institution and personal opinion, should become more apparent.

Interventions

  • Procedure: Video Assisted Thorascopic Surgery Thoracostomy Tube Placement & Drainage

Clinical Trial Outcome Measures

Primary Measures

  • establish morbidity outcomes
  • duration of fever
  • number of procedures
  • days with a chest drainage device
  • total hospital days

Secondary Measures

  • Days of oxygen requirement
  • Days of narcotic use
  • Complication rate
  • Number of radiographic procedures

Participating in This Clinical Trial

Inclusion Criteria

1. consecutive pediatric patients with a bacterial pneumonia and parapneumonic effusion 2. community acquired disease 3. children age 0 to 18 years Exclusion Criteria:

1. hospital acquired pneumonia 2. thoracentesis or chest tube drainage outside hospital 3. patients with incorrected cardiac disease

Gender Eligibility: All

Minimum Age: 0 Years

Maximum Age: 18 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Spectrum Health Hospitals
  • Collaborator
    • Helen DeVos Children’s Hospital
  • Overall Official(s)
    • John Winters, MD, Principal Investigator, Helen DeVos Children’s Hospital

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.